Preferred Label : Sacituzumab Govitecan;

NCIt synonyms : hRS7-SN38 Antibody Drug Conjugate; RS7-SN38; Sacituzumab Govitecan-hziy;

NCIt definition : An antibody drug conjugate containing the humanized monoclonal antibody, hRS7, against tumor-associated calcium signal transducer 2 (TACSTD2 or TROP2) and linked to the active metabolite of irinotecan, 7-ethyl-10-hydroxycamptothecin (SN-38), with potential antineoplastic activity. The antibody moiety of sacituzumab govitecan selectively binds to TROP2. After internalization and proteolytic cleavage, SN-38 selectively stabilizes topoisomerase I-DNA covalent complexes, resulting in DNA breaks that inhibit DNA replication and trigger apoptosis. TROP2, also known as epithelial glycoprotein-1 (EGP-1), is a transmembrane calcium signal transducer that is overexpressed by a variety of human epithelial carcinomas; this antigen is involved in the regulation of cell-cell adhesion and its expression is associated with increased cancer growth, aggressiveness and metastasis.;

UNII : M9BYU8XDQ6;

CAS number : 1491917-83-9;

Drug name : Trodelvy;

Molecule name : IMMU-132; RS7SN38; IMMU 132; RS7 SN38;

Codes from synonyms : 456;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3537214/fr/trodelvy-sacituzumab-govitecan-cancer-du-sein
2024
false
false
false
France
evaluation of the transparency committee
neoplasm, malignant
Sacituzumab Govitecan
Male Breast Carcinoma
sacituzumab govitecan
breast neoplasms
breast cancer
sacituzumab govitecan
Childhood Breast Carcinoma

---
Nous contacter.
01/06/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.